AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Perspective Therapeutics, Inc. Director's Dealing 2022

Aug 19, 2022

33510_dirs_2022-08-19_fee1beb5-014d-46b1-9560-c3b44245e9a9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Isoray, Inc. (ISR)
CIK: 0000728387
Period of Report: 2022-08-18

Reporting Person: Streeter Jennifer (COO & VP of HR)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-08-18	Common Stock	M	50000	$0.43	Acquired	87940	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-08-18	Stock Options (right to buy)	$0.43	M	50000	Disposed	2029-06-18	Common Stock (100000)	Direct

Footnotes

F1: 150,000 stock options were granted on 6/18/2019. 25% vested on 6/18/2019, 25% vested on 6/18/2020, 25% vested on 6/18/2021 and the remaining 25% vested on 6/18/2022.